We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Hubrecht Institute Licenses Flow Eighteen38 Reagent Antibodies for Cancer Research

Product News   May 12, 2021

 
Hubrecht Institute Licenses Flow Eighteen38 Reagent Antibodies for Cancer Research
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Indica Labs Partners With Ibex To Deliver AI-Powered Clinical Workflows

Product News

Indica Labs and Ibex Medical Analytics have announced an agreement to integrate the Galen™ AI-based cancer diagnostics platform into the HALO AP® digital pathology workflow platform.

READ MORE

GammaDelta Therapeutics Receives FDA Clearance For Novel Cell Cancer Therapy

Product News

GammaDelta Therapeutics has announced that the U.S. Food and Drug Administration has cleared the Investigational New Drug application for the Company’s allogeneic variable delta 1 (Vδ1) gamma-delta (γδ) T cell therapy,

READ MORE

Biotinylated Heparan Sulfate Antibodies

Product News

AMSBIO has launched two new biotinylated formats of the 10E4 Heparan Sulfate antibody (high and low biotin) along with a starter pack to allow scientists to test both formats at a reduced cost.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE